BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 19, 2013
View Archived Issues
Royalty Pharma makes firm offer to acquire Elan
Read More
Association between rs17587 polymorphism of the PSMB9 gene and RA
Read More
Pfenex and Agila Biotech form joint venture to develop biosimilar products
Read More
Genentech presents data for novel PI3K inhibitors
Read More
Stem Cell Therapeutics licenses rights to cancer stem cell program
Read More
GPR40 agonist shows improved pharmacokinetics and selectivity
Read More
BioLineRx phase IIa study in ulcerative colitis meets primary endpoint
Read More
CanBas reports topline results from phase II trial of CBP-501 in NSCLC
Read More
Novel radioligands developed for 5-HT4 receptor imaging
Read More
PharmAthene's rBChE shown to bind to broad spectrum of nerve agents
Read More
Researchers from Ontario identify miR-605 as a novel genetic modifier in LFS
Read More
Tekmira presents preliminary phase I results for TKM-080301
Read More
Adelaide Research and Innovation presents new pneumococcal vaccines
Read More
IgenMed Pharmaceuticals presents novel fusion proteins
Read More
New bispecific antibodies divulged by Amgen
Read More
Merck & Co. discloses novel aldosterone synthase inhibitors
Read More
FDA clears SKL-15508 IND
Read More
ARMGO Pharma receives MDA support to advance novel DMD drug
Read More
Phase II trial of AeroVanc begins for MRSA lung infection in patients with cystic fibrosis
Read More
Resverlogix completes dosing in phase IIb ASSURE trial
Read More
Pluristem Therapeutics expands PLX pipeline in orthopedics and sports medicine
Read More
Targacept completes recruitment in phase IIb trial of TC-5619
Read More
Addex Therapeutics reports preclinical data for dipraglurant
Read More
Interprotein and Takeda sign new molecular design agreement
Read More
SK Biopharmaceuticals and SK Chemicals establish alliance for YKP-10811
Read More
Shin Nippon Biomedical and Besins Healthcare sign nasal drug delivery agreement
Read More
Pharmacyclics updates progression of ibrutinib trials
Read More